Оptimization of therapy for gastroesophageal reflux disease in comorbidity with functional dyspepsia

Mirvosit M. Karimov , Pulat S. Zufarov , Guzal N. Sobirova,  Shahlo S. Aripdjanova, Dildora K. Karimova

dc.contributor.author	Mirvosit M. Karimov , Pulat S. Zufarov , Guzal N. Sobirova, Shahlo S. Aripdjanova, Dildora K. Karimova
dc.date.accessioned	2023-01-10T06:58:25Z
dc.date.available	2023-01-10T06:58:25Z
dc.date.issued	2022
dc.identifier.issn	2181-1326
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5725
dc.description.abstract	It has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.	en_US
dc.language.iso	en	en_US
dc.publisher	Central Asian Journal of Medicine	en_US
dc.subject	gastroesophageal reflux disease, functional dyspepsia, proton pump inhibitors, prokinetics.	en_US
dc.title	Оptimization of therapy for gastroesophageal reflux disease in comorbidity with functional dyspepsia	en_US
dc.type	Article	en_US